Found 16 matching trials
EBOla Post-Exposure Prophylaxis
PHASE3EBO-PEP is a multicentre, multi-epidemic, phase III, comparative, controlle...
Location
National Institute for Biomedical Research (INRB)
A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.
PHASE1Previous Ebola outbreaks have been limited to individual countries and cont...
Location
KEMRI Wellcome Trust Research Programme
STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)
PHASE2The 2014 outbreak of Ebola in West Africa is the largest in recorded histor...
Location
College of Medicine and Allied Health Sciences (COMAHS)
Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines
N/AThe aim of this study is to investigate the persistence of the vaccine indu...
Location
MRC - University of Glasgow Centre for Virus Research
African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
PHASE2This is a randomized, placebo-controlled, multi-site, double-blind trial of...
Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure
PHASE3This study is a multi-center, open label, randomized phase 3b trial to asse...
Location
University Hospital Frankfurt (KGU)
Prophylaxis Vaccine Antibodies Ebola
PHASE2* Three measures are currently being implemented to control Ebola outbreaks...
Location
Centre de Traitement Ebola de N'Zerekore
Immune Durability After VSV-EBOV Vaccination
N/AThis prospective observational cohort study will follow the roughly 100 adu...
Location
Multiple Locations
VSV-ZEBOV Geneva Vaccine Trial
PHASE1The hemorrhagic fever resulting from Ebola infection is frequently fatal; t...
Location
University Hospitals of Geneva
Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine
PHASE1Background:
Ebola virus has infected and killed people, mostly in Africa. ...
Location
Multiple Locations